Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population‐based analysis
- 27 July 2013
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 163 (1) , 40-46
Abstract
Summary: Novel treatments for multiple myeloma (MM) have shown promising results in clinical trials, but the advantage in unselected patients is still unclear. In order to evaluate whether novel therapies impact survival of MM patients, we performed a population‐based analysis on data collected by the Modena Cancer Registry from 1989 to 2009. The analysis evaluated 1206 newly diagnosed MM patients collected in the years 1988–96 (conventional therapy), 1997–05 (high dose melphalan and autologous transplant), and 2006–09 (novel agents era). Both relative survival (RS) and overall survival (OS) improved over the years, but not equally in the three groups. For patients aged <65 years, RS improved in 1997–05 and 2006–09 compared with previous years and a trend to improvement was observed from 1997–05 to 2006–09. For patients aged 65–74 years, RS improved significantly in 2006–09 compared with 1988–96 and 1997–05. No amelioration was observed for patients 75+ years old. OS confirmed RS. In conclusion, the survival of MM patients aged <65 and, in particular, 65–74 years, has improved over time, especially after 2006. This observation provides circumstantial evidence that novel therapies might impact patient survival. Despite the limits of this study, these data refer to an unselected population, giving a picture of every day clinical practice.Keywords
This publication has 14 references indexed in Scilit:
- Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel AgentsBlood, 2012
- Survival outcomes in elderly patients with plasma cell myeloma: The three-decade Eastern Cooperative Oncology Group (ECOG) experience.Journal of Clinical Oncology, 2011
- Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working GroupBlood, 2008
- Improved survival in multiple myeloma and the impact of novel therapiesBlood, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003Journal of Clinical Oncology, 2007
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Regression models for relative survivalStatistics in Medicine, 2003
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972